- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Pandemic Has Shown Indian Pharma Industry Is An Asset For World: PM Narendra Modi
"Vaccines made in India are responsible for two-third of the vaccine needs of the world's children. Even today, our companies are actively contributing in the international efforts for the development and production of COVID-19 vaccine," the Prime Minister said.
New Delhi: In a virtual global address, Prime Minister Narendra Modi on Thursday said the Indian pharmaceutical industry has been an "asset" not just for its own country but also for the entire world as it leads to "reducing the cost of medicine" for developing countries.
"The pandemic has once again shown that India's pharma industry is an asset not just for India but for the entire world. It has played a leading role in reducing the cost of medicines especially for developing countries," the Prime Minister said while speaking at the India Global Week 2020.
He also highlighted how vaccines developed in India cater to the masses and the country will contribute in the fight against COVID-19 pandemic globally.
"Vaccines made in India are responsible for two-third of the vaccine needs of the world's children. Even today, our companies are actively contributing in the international efforts for the development and production of COVID-19 vaccine," the Prime Minister said.
Talking about the future prospects and the role of India in vaccine production, the Prime Minister added, "I am certain that India will have an important role in developing and in scaling up production of the vaccine once it is discovered."
The Prime Minister further went on to call Indians as "natural reformers" and further added that history is proof of that.
"Indians are natural reformers. History shows that India has overcome every challenge be it social or economic. On one hand, India is fighting a strong battle against the global pandemic. With an increased focus on people's health, we are equally focussed on the health of the economy," the Prime Minister added.
The India Global Week 2020 is a three-day virtual conference, being held from July 9 to July 11, themed 'Be The Revival: India and a Better New World', will have 5,000 global participants from 30 nations being addressed by 250 global speakers across 75 sessions.
Read also: Several short, long-term efforts required to revive pharma ancillary industry: IPA
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751